Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
Journal Club

Canonical Wnt Signalling in PDGFRα-Expressing Cells is a Critical Regulator of Astrogliosis and Axon Regeneration following CNS Injury

Greg J. Duncan, Peggy Assinck and Brett J. Hilton
Journal of Neuroscience 3 December 2014, 34 (49) 16163-16165; DOI: https://doi.org/10.1523/JNEUROSCI.4052-14.2014
Greg J. Duncan
1International Collaboration on Repair Discoveries,
2Department of Zoology, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peggy Assinck
1International Collaboration on Repair Discoveries,
3Graduate Program in Neuroscience, The University of British Columbia, Vancouver, British Columbia, Canada V5Z 1M9
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brett J. Hilton
1International Collaboration on Repair Discoveries,
2Department of Zoology, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Spinal cord injury (SCI) in the mammalian CNS results in the formation of a glial scar around the lesion site (Fig. 1A). The scar limits axon regeneration but it also serves a protective role by sequestering inflammatory cells to the lesion center, reducing tissue damage (Herrmann et al., 2008). Although astrocytes have been thought to be the primary cellular source of the glial scar, recent work suggests the scar is comprised of a complex milieu of interacting cell types, including perivascular fibroblasts, stromal cells, inflammatory cells, and oligodendrocyte precursor cells (OPCs) (Cregg et al., 2014). OPCs, distinguishable from mature oligodendrocytes by their expression of NG2 and PDGFRα, rapidly proliferate and form new oligodendrocytes in the spared parenchyma after injury, likely mediating myelin repair (Tripathi and McTigue, 2007). However, proximal to the lesion core, OPCs are found at very high densities, often in close association with the dystrophic end-bulbs of axons that have failed to regenerate (Cregg et al., 2014). Given the interaction of NG2 cells with dystrophic end-bulbs of axons in the lesion, it seems plausible that reducing their contribution to scarring might enhance regeneration.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Deletion of β-catenin from NG2 glia before SCI reduces astrogliosis and inflammation. A, An overview of the cellular response to SCI by glial and inflammatory cells. A prominent glial scar containing hypertrophic astrocytes (purple) and inflammatory microglia/macrophages (blue) is formed. NG2 glia (green) proliferate and accumulate around the lesion. They express Wnt target genes after SCI. A′, β-catenin is the downstream signal inducer of canonical Wnt signaling. When Wnt ligands bind to the Frizzled receptor, Dishevelled (DVL)-LRP-Frizzled recruits the Axin complex to the receptors, allowing β-catenin to drive Wnt target gene expression in conjunction with the TCF/LEF family of transcription factors. B, ICKO of β-catenin reduces astrogliosis, CSPG expression (yellow), microglial/macrophage accumulation, and NG2 recruitment to the lesion. Lacking hypertrophic astrocytes, the boundary of the glial scar does not form a compact border. B′, β-catenin deletion inhibits Wnt target gene expression in the presence of Wnt ligands.

Wnt signaling is a likely candidate to regulate the OPC response after SCI. Oligodendrocyte development and OPC differentiation in demyelinating lesions are regulated by Wnt signaling (Fancy et al., 2011) and following SCI, Wnt ligand expression is increased (Fernández-Martos et al., 2011). β-catenin is an intracellular signal transducer in the Wnt signaling pathway (Fig. 1A′) and its deletion effectively halts canonical Wnt target gene expression (Fig. 1B′). In a recent study, Rodriguez et al. (2014) modulated the OPC response to CNS trauma by deleting β-catenin from PDGFRα-expressing cells, a population that includes OPCs. The authors crossed PDGFRαcreERT2 mice with floxed β-catenin mice to excise β-catenin when tamoxifen is administered, just before SCI. Inducible expression of yellow fluorescent protein allowed tracking of the fate of recombined cells.

Rodriguez et al. (2014) first examined the effect of inducible deletion of β-catenin from PDGFRα-expressing cells on OPC density and proliferation in both the uninjured and injured CNS. The removal of β-catenin did not affect the percentage of cells that remained as OPCs (defined by the authors as expressing NG2) in the uninjured CNS 25 d later (Rodriguez et al., 2014, their Fig. 1C). This suggests that β-catenin deletion does not alter OPC differentiation in the uninjured CNS during this timeframe. However, after SCI, β-catenin inducible conditional knock-out (ICKO) mice had reduced NG2 cell density and proliferation, such that these cells failed to accumulate around the lesion (Fig. 1B) (Rodriguez et al., 2014, their Fig. 3). Because inhibiting canonical Wnt signaling promotes differentiation of OPCs in chemical demyelinating models (Fancy et al., 2011), accelerated differentiation of OPCs could explain the reduction in NG2 cell density observed by Rodriguez et al. (2014). The authors did not assess whether β-catenin deletion was sufficient to enhance OPC differentiation into mature oligodendrocytes after injury, however. Doing so may have yielded insight into the fate of these cells and their capacity to remyelinate.

Rodriguez et al. (2014) next examined astrogliosis and inflammation in β-catenin ICKO mice subjected to SCI. Astrogliosis was reduced in β-catenin ICKO mice; specifically, there were reductions in astrocyte hypertrophy, chondroitin sulfate proteoglycan (CSPG) expression, and formation of the compact glial fibrillary acidic protein (GFAP) lesion border typical of the glial scar (Fig. 1B) (Rodriguez et al., 2014, their Figs. 5 and 6). Interestingly, the level of microglia/macrophage inflammation was also sharply reduced in the penumbra of β-catenin ICKO mice (Rodriguez et al., 2014, their Fig. 4). This comes as a surprise, as a failure of astroglial scar formation has previously been implicated in exacerbated microglia/macrophage spread and accumulation (Herrmann et al., 2008). However, in Rodriguez et al. (2014), changes in microglia/macrophage density occurred concurrently with changes in NG2 density but before the formation of a mature glial scar, indicating that OPCs may directly affect inflammation independently of subsequent astrogliosis.

Recent studies (Kang et al., 2013; Yuen et al., 2014) shed light on how OPCs might regulate inflammation following SCI. The amassing of inflammatory microglia/macrophages after SCI results from both local microglia proliferation/migration as well as the accumulation of blood-derived macrophages (Cregg et al., 2014). Importantly, Rodriguez et al. (2014) demonstrated that microglia/macrophage cell proliferation was not disrupted following β-catenin deletion (Rodriguez et al., 2014, their Fig. 4C), implying that β-catenin deletion from OPCs may be affecting the accumulation of blood-derived macrophages. Macrophage accumulation occurs concurrently with revascularization of the tissue (Casella et al., 2002). Recent work by Yuen et al. (2014) suggests that OPCs promote brain angiogenesis by directly inducing endothelial cell proliferation and blood vessel formation during development. Furthermore, OPCs regulate inflammation in experimental autoimmune encephalomyelitis by proinflammatory cytokine production and by promoting blood–brain barrier permeability (Kang et al., 2013). Thus, an intriguing possibility is that dampened inflammation in β-catenin ICKO mice following SCI is the result of an impairment in OPC-induced proinflammatory signals and angiogenesis, which is required for macrophage infiltration. Future studies should examine the role of OPCs in the formation of new vasculature after traumatic injury and the subsequent impact on the ability of monocytes to enter damaged tissue.

β-catenin ICKO from PDGFRα-expressing cells reduces injury-induced astrogliosis and CSPG expression, a known inhibitor of axon regeneration. Therefore, the knock-out may produce an environment permissive to axonal regeneration. To test this hypothesis, Rodriguez et al. (2014) crushed the optic nerve in β-catenin ICKO and control mice. β-catenin ICKO mice had less accumulation of recombined cells at the lesion site and greater axon growth up to 1 mm past the lesion relative to control (Rodriguez et al., 2014, their Fig. 7). Therefore, β-catenin deletion in PDGFRα-expressing cells promoted axon regeneration in the optic nerve. No histological assessment was made of supraspinal axon growth after SCI, which would demonstrate whether Wnt signaling in PDGFRα-expressing cells restricts axon growth following SCI.

Although Rodriguez et al. (2014) attribute the changes in astrocytic, inflammatory, and regenerative responses following injury to abrogation of β-catenin in OPCs specifically, it is worth noting that PDGFRα is also expressed in pericytes (Göritz et al., 2011). Indeed, recombination in pericytes of PDGFRαcreER mice occurs after tamoxifen administration (Kang et al., 2010), so the mice used by Rodriguez et al. (2014) (β-cateninfl/fl:PDGFRαcreERT2) would lack β-catenin in PDGFRα-expressing pericytes. Considering that pericytes in the CNS can also express NG2 (Ozerdem et al., 2001), the marker Rodriguez et al. (2014) use for OPCs, measurements of both NG2 and recombined cell density after SCI in β-catenin ICKO may also reflect changes in pericyte density. Pericytes have a robust role after SCI: they dissociate from the vasculature and contribute extensively to fibrosis within the lesion core (Göritz et al., 2011). In addition, studies on kidney fibrosis suggests that Wnt signaling is active in pericytes and drives their differentiation into myofibroblasts (DiRocco et al., 2013). These myofibroblasts express αSMA like some pericyte-derived cells do after SCI (Göritz et al., 2011). Together, this evidence suggests a role for β-catenin in the accumulation and possibly the differentiation of fibrotic pericyte derived-cells after SCI. Changes in astrogliosis, inflammation, and axon regeneration described by Rodriguez et al. (2014) might result, at least in part, from pericytic β-catenin deletion.

In summary, the work of Rodriguez et al. (2014) highlights a critical role for β-catenin in PDGFRα-expressing cells to promote astrogliosis and inflammation, and attenuate axon regeneration after injury. The pathway has been modulated in vivo using small molecule inhibitors (Fancy et al., 2011) and evidence from Rodriguez et al. (2014) strongly suggests that reducing Wnt signaling warrants therapeutic investigation for SCI.

Footnotes

  • Editor's Note: These short, critical reviews of recent papers in the Journal, written exclusively by graduate students or postdoctoral fellows, are intended to summarize the important findings of the paper and provide additional insight and commentary. For more information on the format and purpose of the Journal Club, please see http://www.jneurosci.org/misc/ifa_features.shtml.

  • G.J.D. is supported by a Multiple Sclerosis Society of Canada Doctoral Trainee Scholarship. P.A. and B.J.H. are both supported by Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Doctoral Graduate Scholarships. We thank Jason Plemel for his critical review and feedback on this manuscript. We would also like to thank Dr. Wolfram Tetzlaff for his supervision and support as well as the entire Tetzlaff lab for the stimulating discussions on spinal cord repair.

  • Correspondence should be addressed to Greg J. Duncan, ICORD, Blusson Spinal Cord Centre, 818 West 10th Vancouver, British Columbia, Canada, V5Z 1M9. duncan{at}icord.org. Phone: 1-604-675-8839

References

  1. ↵
    1. Casella GT,
    2. Marcillo A,
    3. Bunge MB,
    4. Wood PM
    (2002) New vascular tissue rapidly replaces neural parenchyma and vessels destroyed by a contusion injury to the rat spinal cord. Exp Neurol 173:63–76, doi:10.1006/exnr.2001.7827, pmid:11771939.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Cregg JM,
    2. DePaul MA,
    3. Filous AR,
    4. Lang BT,
    5. Tran A,
    6. Silver J
    (2014) Functional regeneration beyond the glial scar. Exp Neurol 253:197–207, doi:10.1016/j.expneurol.2013.12.024, pmid:24424280.
    OpenUrlCrossRefPubMed
  3. ↵
    1. DiRocco DP,
    2. Kobayashi A,
    3. Taketo MM,
    4. McMahon AP,
    5. Humphreys BD
    (2013) Wnt4/beta-catenin signaling in medullary kidney myofibroblasts. J Am Soc Nephrol 24:1399–1412, doi:10.1681/ASN.2012050512, pmid:23766539.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Fancy SP,
    2. Harrington EP,
    3. Yuen TJ,
    4. Silbereis JC,
    5. Zhao C,
    6. Baranzini SE,
    7. Bruce CC,
    8. Otero JJ,
    9. Huang EJ,
    10. Nusse R,
    11. Franklin RJ,
    12. Rowitch DH
    (2011) Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination. Nat Neurosci 14:1009–1016, doi:10.1038/nn.2855, pmid:21706018.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Fernández-Martos CM,
    2. González-Fernández C,
    3. González P,
    4. Maqueda A,
    5. Arenas E,
    6. Rodríguez FJ
    (2011) Differential expression of Wnts after spinal cord contusion injury in adult rats. PloS One 6:e27000, doi:10.1371/journal.pone.0027000, pmid:22073235.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Göritz C,
    2. Dias DO,
    3. Tomilin N,
    4. Barbacid M,
    5. Shupliakov O,
    6. Frisén J
    (2011) A pericyte origin of spinal cord scar tissue. Science 333:238–242, doi:10.1126/science.1203165, pmid:21737741.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Herrmann JE,
    2. Imura T,
    3. Song B,
    4. Qi J,
    5. Ao Y,
    6. Nguyen TK,
    7. Korsak RA,
    8. Takeda K,
    9. Akira S,
    10. Sofroniew MV
    (2008) STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J Neurosci 28:7231–7243, doi:10.1523/JNEUROSCI.1709-08.2008, pmid:18614693.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Kang SH,
    2. Fukaya M,
    3. Yang JK,
    4. Rothstein JD,
    5. Bergles DE
    (2010) NG2+ CNS glial progenitors remain committed to the oligodendrocyte lineage in postnatal life and following neurodegeneration. Neuron 68:668–681, doi:10.1016/j.neuron.2010.09.009, pmid:21092857.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Kang Z,
    2. Wang C,
    3. Zepp J,
    4. Wu L,
    5. Sun K,
    6. Zhao J,
    7. Chandrasekharan U,
    8. DiCorleto PE,
    9. Trapp BD,
    10. Ransohoff RM,
    11. Li X
    (2013) Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2+ glial cells. Nat Neurosci 16:1401–1408, doi:10.1038/nn.3505, pmid:23995070.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Ozerdem U,
    2. Grako KA,
    3. Dahlin-Huppe K,
    4. Monosov E,
    5. Stallcup WB
    (2001) NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis. Dev Dyn 222:218–227, doi:10.1002/dvdy.1200, pmid:11668599.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Rodriguez JP,
    2. Coulter M,
    3. Miotke J,
    4. Meyer RL,
    5. Takemaru K,
    6. Levine JM
    (2014) Abrogation of beta-catenin signaling in oligodendrocyte precursor cells reduces glial scarring and promotes axon regeneration after CNS injury. J Neurosci 34:10285–10297, doi:10.1523/JNEUROSCI.4915-13.2014, pmid:25080590.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Tripathi R,
    2. McTigue DM
    (2007) Prominent oligodendrocyte genesis along the border of spinal contusion lesions. Glia 55:698–711, doi:10.1002/glia.20491, pmid:17330874.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Yuen TJ,
    2. Silbereis JC,
    3. Griveau A,
    4. Chang SM,
    5. Daneman R,
    6. Fancy SP,
    7. Zahed H,
    8. Maltepe E,
    9. Rowitch DH
    (2014) Oligodendrocyte-encoded HIF function couples postnatal myelination and white matter angiogenesis. Cell 158:383–396, doi:10.1016/j.cell.2014.04.052, pmid:25018103.
    OpenUrlCrossRefPubMed
Back to top

In this issue

The Journal of Neuroscience: 34 (49)
Journal of Neuroscience
Vol. 34, Issue 49
3 Dec 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Advertising (PDF)
  • Ed Board (PDF)
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Canonical Wnt Signalling in PDGFRα-Expressing Cells is a Critical Regulator of Astrogliosis and Axon Regeneration following CNS Injury
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Canonical Wnt Signalling in PDGFRα-Expressing Cells is a Critical Regulator of Astrogliosis and Axon Regeneration following CNS Injury
Greg J. Duncan, Peggy Assinck, Brett J. Hilton
Journal of Neuroscience 3 December 2014, 34 (49) 16163-16165; DOI: 10.1523/JNEUROSCI.4052-14.2014

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Canonical Wnt Signalling in PDGFRα-Expressing Cells is a Critical Regulator of Astrogliosis and Axon Regeneration following CNS Injury
Greg J. Duncan, Peggy Assinck, Brett J. Hilton
Journal of Neuroscience 3 December 2014, 34 (49) 16163-16165; DOI: 10.1523/JNEUROSCI.4052-14.2014
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

  • Adult-Born Granule Cells Contribute to Dentate Gyrus Circuit Reorganization after Traumatic Brain Injury
  • The Oscillatory Nature of Movement Initiation
  • Lateral Preoptic Hypothalamus: A Window to Understanding Insomnia
Show more Journal Club
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
(JNeurosci logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.